To strengthen accountability measures for the safekeeping of confidential prescription information after statutorily authorized release from the database.

 

DEPARTMENT OF HEALTH
Prescription Drug Monitoring Program

RULE NOS.:RULE TITLES:
64K-1.003Accessing Database
64K-1.004Management and Operation of Database
64K-1.005Privacy of Information
PURPOSE AND EFFECT: To strengthen accountability measures for the safekeeping of confidential prescription information after statutorily authorized release from the database.
SUBJECT AREA TO BE ADDRESSED: The Department will develop rules establishing procedures for acquiring both direct and indirect access to the database, procedures for revoking access to the database, standards for the denial of requests for direct and indirect access to the database, as well as any other measures related to access, database operation or database management identified during the rulemaking process as promoting the privacy of confidential prescription information after statutorily authorized release from the database.
RULEMAKING AUTHORITY: 893.055 FS.
LAW IMPLEMENTED: 893.055, 893.0551 FS.
A RULE DEVELOPMENT WORKSHOP WILL BE HELD AT THE DATE, TIME AND PLACE SHOWN BELOW:
DATE AND TIME: Monday, July 8, 2013, 8:30 a.m. – 1:00 p.m.
PLACE: Florida Department of Health, 4052 Bald Cypress Way, Room 301, Tallahassee, Florida 32399
Pursuant to the provisions of the Americans with Disabilities Act, any person requiring special accommodations to participate in this workshop/meeting is asked to advise the agency at least 5 days before the workshop/meeting by contacting: Rebecca Poston, Program Manager, Prescription Drug Monitoring Program, 4052 Bald Cypress Way, Bin #C-16, Tallahassee, Florida 32399 or email address: [e-mail]. If you are hearing or speech impaired, please contact the agency using the Florida Relay Service, 1(800)955-8771 (TDD) or 1(800)955-8770 (Voice).
THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE DEVELOPMENT AND A COPY OF THE PRELIMINARY DRAFT, IF AVAILABLE, IS: Rebecca Poston, Program Manager, Prescription Drug Monitoring Program, 4052 Bald Cypress Way, Bin #C-16, Tallahassee, Florida 32399 or email address: [e-mail]
THE PRELIMINARY TEXT OF THE PROPOSED RULE DEVELOPMENT IS NOT AVAILABLE.